Shanghai Drug Maker Gets $97 Mln From Fidelity, GIC, Qiming, Others

The Covid-19 pandemic has put China’s pharmaceutical, medical an healthcare industries in the global spotlight.

Read the full post on Forbes - Healthcare

Russell Flannery, Forbes Staff